Skip to the page

Data / Drug companies / Moehs Catalana SL

Moehs Catalana SL: 21 products in the FDA NDC directory, labeler code 52932

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Moehs Catalana SL (labeler code 52932) lists 21 products in the FDA National Drug Code Directory. By type: 21 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 2, 2015.

The request: Watch Moehs Catalana SL (FDA labeler code 52932): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
52932
Products in commercial distribution
21
Packages
21
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
September 29, 2009
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients21100%

Products by type

TypeProductsShare
Bulk ingredients21100%

Dosage forms

Dosage formProductsShare
Powder21100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Carvedilol52932-0726PowderBulk ingredientsFebruary 2, 2015
Metoprolol tartrate52932-0743PowderBulk ingredientsJune 27, 2013
Amlodipine besylate52932-0723PowderBulk ingredientsJuly 23, 2010
Sumatriptan52932-0733PowderBulk ingredientsOctober 28, 2009
Sumatriptan succinate52932-0727PowderBulk ingredientsOctober 28, 2009
Sotalol hydrochloride52932-0715PowderBulk ingredientsOctober 28, 2009
Triamterene52932-0703PowderBulk ingredientsOctober 28, 2009
Rabeprazole sodium52932-0736PowderBulk ingredientsSeptember 29, 2009
Mepivacaine hydrochloride52932-0731PowderBulk ingredientsSeptember 29, 2009
Lansoprazole52932-0730PowderBulk ingredientsSeptember 29, 2009
Bupivacaine hydrochloride52932-0729PowderBulk ingredientsSeptember 29, 2009
Metoprolol tartrate ds/ip52932-0721PowderBulk ingredientsSeptember 29, 2009
Bisoprolol fumarate52932-0720PowderBulk ingredientsSeptember 29, 2009
Pyrantel pamoate52932-0714PowderBulk ingredientsSeptember 29, 2009
Metoprolol succinate52932-0713PowderBulk ingredientsSeptember 29, 2009
Nifedipine52932-0711PowderBulk ingredientsSeptember 29, 2009
Metoprolol tartrate52932-0710PowderBulk ingredientsSeptember 29, 2009
Amantadine hydrochloride52932-0707PowderBulk ingredientsSeptember 29, 2009
Acetylcysteine52932-0704PowderBulk ingredientsSeptember 29, 2009
Lidocaine52932-0702PowderBulk ingredientsSeptember 29, 2009
Lidocaine hydrochloride52932-0701PowderBulk ingredientsSeptember 29, 2009

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.